Elsevier

The Lancet

Volume 375, Issue 9715, 20–26 February 2010, Page 637
The Lancet

Correspondence
The need for new antibiotics

https://doi.org/10.1016/S0140-6736(10)60264-4Get rights and content

References (5)

There are more references available in the full text version of this article.

Cited by (9)

  • Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study

    2010, The Lancet Infectious Diseases
    Citation Excerpt :

    Now, however, clinical microbiologists increasingly agree that multidrug-resistant Gram-negative bacteria pose the greatest risk to public health. Not only is the increase in resistance of Gram-negative bacteria faster than in Gram-positive bacteria,1,2 but also there are fewer new and developmental antibiotics active against Gram-negative bacteria3–6 and drug development programmes seem insufficient to provide therapeutic cover in 10–20 years.7–9 The increase in resistance of Gram-negative bacteria is mainly due to mobile genes on plasmids that can readily spread through bacterial populations.

  • RF atmospheric plasma jet surface treatment of paper

    2016, Journal of Physics D: Applied Physics
View all citing articles on Scopus
View full text